SCHEMBL17405752

SCHEMBL17405752

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-n4c5ccccc5c5c6c7ccccc7n(-c7ccccc7)c6c6sc7ccccc7c6c54)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.37
MEN1 O00255 7/20 0.37
MAPT P10636 7/20 0.37
HPGD P15428 7/20 0.37
ALDH1A1 P00352 6/20 0.37
NTSR1 P30989 1/20 0.37
KDM4E B2RXH2 5/20 0.34
LMNA P02545 2/20 0.34
GLA P06280 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTK2B Q14289 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17405492 1.00 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17405745 1.00 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17405482 1.00 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17405807 0.97 KMT2A (0.36) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17406030 0.97 KMT2A (0.36) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17405797 0.97 KMT2A (0.36) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17406029 0.97 KMT2A (0.36) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL17405414 0.96 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL16275648 0.96 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL16275907 0.96 KMT2A (0.37) KMT2AMEN1MAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE ODC1, NOTUM, OR10J3 KMT2A 1292/4885MEN1 1833/4885MAPT 2869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.